MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Treating Upper Limb Spasticity With OnabotulinumtoxinA: Subgroup Analysis of US Practice Patterns From the ASPIRE Study

    G. Francisco, W. Feng, M. Munin, K. Ngo, M. Schwartz, M. Sadeghi, A. Zuzek, A. Esquenazi (Houston, USA)

  • Treatment of upper limb dystonic tremors: a retrospective study

    B. Gonzalez-Herrero, I. Di Vico, M. Edwards, F. Morgante (London, United Kingdom)

  • Treatment Selection in Multi-Arm Multi-Stage Clinical Trials in Parkinson Disease: The Search for the Ideal Neuroprotective Drug

    C. Gonzalez-Robles, D. Byrom, R. Chapman, D. Dexter, S. Duty, R. Ellis-Doyle, E. Jabbari, G. Mills, H. Mortiboys, J. Rudiger, E. Sammler, P. Scurfield, S. Stott, G. Tofaris, L. Wei, A. Wong, ML. Zeissler, C. Carroll, T. Foltynie, O. Bandmann, A. Schapira (London, United Kingdom)

  • TREMOR AND BRADYKINESIA ARE TWO UNRELATED SIDE EFFECTS INDUCED BY VALPROATE INTAKE

    A. de Biase, G. Paparella, L. Angelini, A. Cannavacciuolo, D. Colella, E. Cerulli Irelli, A. Gialllonardo, C. Di Bonaventura, A. Berardelli, M. Bologna (Rome, Italy)

  • Tremor as a Hallmark of Neurodegeneration and Mercury Intoxication

    D. Labunskiy, S. Kiryukhina, N. Kolmykova, N. Kurgaev (Saransk, Russian Federation)

  • Tremor genetics in clinical practice: a systematic literature review

    C. Everlo, M. Tijssen, C. Marras, C. Klein, D. Verbeek, T. de Koning, M. V.D. Stouwe (Groningen, Netherlands)

  • Tremor in patients with myotonic dystrophy type 2

    N. Dragašević Mišković, A. Milovanovic, S. Perić, M. Badža, B. Bjelica, I. Vajs, V. Bobić, č. Jovanović, V. Rakočević, I. Basta, M. Svetel, M. đurić, V. Kostić (Belgrade)

  • Trending the educational needs of US physicians related to managing patients with tardive dyskinesia

    W. Cerenzia, S. Wiley, B. Coleman, S. Stacy, E. Jen, K. Farahmand, S. Siegert, C. Shah (Birmingham, USA)

  • Trends in incidence of hospitalizations in Parkinson´s Disease in Spain (2010-2019)

    V. Gómez-Mayordomo, R. Jiménez-García, E. Sanesteban-Beceiro, E. López-Valdés, R. García-Ramos, F. Alonso-Frech (Madrid, Spain)

  • TRPV4 Mutation related Parkinson’s Disease with Scapuloperoneal spinal muscular atrophy

    A. Deenadayalu, P. A, V. Paramanandam (Limerick, Ireland)

  • « Previous Page
  • 1
  • …
  • 143
  • 144
  • 145
  • 146
  • 147
  • …
  • 153
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley